Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has appointed Kevin McRaith as the company's new president. McRaith most recently served as VP of Sales & Marketing at Human Genome Sciences, and previously worked at Genentech, Abbott and Baxter. In this role McRaith will report to WellDoc CEO Ryan Sysko. WellDoc's...
Last August -- almost a year ago now -- The New York Times reported that two insurers had agreed to pay $100 a month in reimbursement for use of WellDoc's mobile-enabled diabetes management program. The report, which sourced WellDoc's president Anand Iyer as its source, expected the payers to begin supporting the "mobile integrated therapy" in early 2013.
This morning WellDoc launched a new...
